Developing effective cancer vaccines: design and monitoring are critical

被引：5

作者：

Armstrong, A ^{[1
]}

Dermime, S ^{[1
]}

机构：

[1] Univ Manchester, Paterson Inst Canc Res, CRC, Dept Med Oncol, Manchester M20 4BX, Lancs, England

来源：

BRITISH JOURNAL OF CANCER | 2001年 / 84卷 / 11期

关键词：

D O I：

10.1054/bjoc.2001.1839

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1433 / 1436

页数：4

共 26 条

[1]

Arthur JF, 1997, CANCER GENE THER, V4, P17

[2] TREATMENT OF METASTATIC MELANOMA WITH AN AUTOLOGOUS TUMOR-CELL VACCINE - CLINICAL AND IMMUNOLOGICAL RESULTS IN 64 PATIENTS [J].

BERD, D ;

MAGUIRE, HC ;

MCCUE, P ;

MASTRANGELO, MJ .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (11) :1858-1867

[3] A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer [J].

Borysiewicz, LK ;

Fiander, A ;

Nimako, M ;

Man, S ;

Wilkinson, GWG ;

Westmoreland, D ;

Evans, AS ;

Adams, M ;

Stacey, SN ;

Boursnell, MEG ;

Rutherford, E ;

Hickling, JK ;

Inglis, SC .

LANCET, 1996, 347 (9014) :1523-1527

[4]

Brossart P, 1997, J IMMUNOL, V158, P3270

[5] VACCINATION WITH IRRADIATED TUMOR-CELLS ENGINEERED TO SECRETE MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR STIMULATES POTENT, SPECIFIC, AND LONG-LASTING ANTITUMOR IMMUNITY [J].

DRANOFF, G ;

JAFFEE, E ;

LAZENBY, A ;

GOLUMBEK, P ;

LEVITSKY, H ;

BROSE, K ;

JACKSON, V ;

HAMADA, H ;

PARDOLL, D ;

MULLIGAN, RC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3539-3543

[6] Increased interleukin-10 serum levels in patients with solid tumours [J].

Fortis, C ;

Foppoli, M ;

Gianotti, L ;

Galli, L ;

Citterio, G ;

Consogno, G ;

Gentilini, O ;

Braga, M .

CANCER LETTERS, 1996, 104 (01) :1-5

[7] TREATMENT OF ESTABLISHED RENAL-CANCER BY TUMOR-CELLS ENGINEERED TO SECRETE INTERLEUKIN-4 [J].

GOLUMBEK, PT ;

LAZENBY, AJ ;

LEVITSKY, HI ;

JAFFEE, LM ;

KARASUYAMA, H ;

BAKER, M ;

PARDOLL, DM .

SCIENCE, 1991, 254 (5032) :713-716

[8] Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group study E5283 [J].

Harris, JE ;

Ryan, L ;

Hoover, HC ;

Stuart, RK ;

Oken, MM ;

Benson, AB ;

Mansour, E ;

Haller, DG ;

Manola, J ;

Hanna, MG .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (01) :148-157

[9] A pilot study of idiotypic vaccination for follicular B-cell lymphoma using a genetic approach [J].

Hawkins, RE ;

Russell, SJ ;

Marcus, R ;

Ashworth, LJ ;

Brissnik, J ;

Zhang, J ;

Winter, G ;

Bleehen, NM ;

Stevenson, F ;

Hamblin, T ;

Oscier, D ;

Zhu, DL ;

King, C ;

Kumar, S ;

Thompsett, A ;

Stevenson, GT .

HUMAN GENE THERAPY, 1997, 8 (10) :1287-1299

[10] A GENETIC APPROACH TO IDIOTYPIC VACCINATION [J].

HAWKINS, RE ;

WINTER, G ;

HAMBLIN, TJ ;

STEVENSON, FK ;

RUSSELL, SJ .

JOURNAL OF IMMUNOTHERAPY, 1993, 14 (04) :273-278

← 1 2 3 →